Literature DB >> 36121551

Exploration of the link between gut microbiota and purinergic signalling.

MingJian Li1, BoWen Liu2, Rong Li2, Ping Yang2, Ping Leng3, Yong Huang4.   

Abstract

Growing evidence reveals that microorganisms in the gut are linked to metabolic health and disease risk in human beings to a considerable extent. The focus of research at this stage must tend to focus on cause-and-effect studies. In addition to being a component of DNA and RNA, purine metabolites can be involved in purine signalling in the body as chemical messengers. Abnormalities in purinergic signalling may lead to neuropathy, rheumatic immune diseases, inflammation, tumors, and a wide range of other diseases. It has proved that gut microbes are involved in purinergic signalling. The relationship between these gut-derived purinergic signalling molecules and host metabolism may be one of the important clues to our understanding of the mechanisms by which the microbiota affects host metabolism.
© 2022. The Author(s).

Entities:  

Keywords:  A2A receptors; Gastrointestinal microbiome; Inosine; P2X receptors; Purinergic signalling

Year:  2022        PMID: 36121551     DOI: 10.1007/s11302-022-09891-1

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.950


  87 in total

Review 1.  Mitochondrial evolution.

Authors:  M W Gray; G Burger; B F Lang
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

Review 2.  Eukaryotic evolution, changes and challenges.

Authors:  T Martin Embley; William Martin
Journal:  Nature       Date:  2006-03-30       Impact factor: 49.962

Review 3.  The Human Intestinal Microbiome in Health and Disease.

Authors:  Susan V Lynch; Oluf Pedersen
Journal:  N Engl J Med       Date:  2016-12-15       Impact factor: 91.245

Review 4.  Gut microbiota in human metabolic health and disease.

Authors:  Yong Fan; Oluf Pedersen
Journal:  Nat Rev Microbiol       Date:  2020-09-04       Impact factor: 60.633

5.  Deep mitochondrial origin outside the sampled alphaproteobacteria.

Authors:  Joran Martijn; Julian Vosseberg; Lionel Guy; Pierre Offre; Thijs J G Ettema
Journal:  Nature       Date:  2018-04-25       Impact factor: 49.962

6.  Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.

Authors:  Lukas F Mager; Regula Burkhard; Nicola Pett; Noah C A Cooke; Kirsty Brown; Hena Ramay; Seungil Paik; John Stagg; Ryan A Groves; Marco Gallo; Ian A Lewis; Markus B Geuking; Kathy D McCoy
Journal:  Science       Date:  2020-08-13       Impact factor: 47.728

Review 7.  A prescription for lifestyle change in patients with hyperuricemia and gout.

Authors:  Hyon K Choi
Journal:  Curr Opin Rheumatol       Date:  2010-03       Impact factor: 5.006

8.  T Follicular Helper Cells Promote a Beneficial Gut Ecosystem for Host Metabolic Homeostasis by Sensing Microbiota-Derived Extracellular ATP.

Authors:  Lisa Perruzza; Giorgio Gargari; Michele Proietti; Bruno Fosso; Anna Maria D'Erchia; Caterina Elisa Faliti; Tanja Rezzonico-Jost; Daniela Scribano; Laura Mauri; Diego Colombo; Giovanni Pellegrini; Annalisa Moregola; Catherine Mooser; Graziano Pesole; Mauro Nicoletti; Giuseppe Danilo Norata; Markus B Geuking; Kathy D McCoy; Simone Guglielmetti; Fabio Grassi
Journal:  Cell Rep       Date:  2017-03-14       Impact factor: 9.423

9.  Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors.

Authors:  Baokun He; Thomas K Hoang; Ting Wang; Michael Ferris; Christopher M Taylor; Xiangjun Tian; Meng Luo; Dat Q Tran; Jain Zhou; Nina Tatevian; Fayong Luo; Jose G Molina; Michael R Blackburn; Thomas H Gomez; Stefan Roos; J Marc Rhoads; Yuying Liu
Journal:  J Exp Med       Date:  2016-12-19       Impact factor: 14.307

Review 10.  From purines to purinergic signalling: molecular functions and human diseases.

Authors:  Zhao Huang; Na Xie; Peter Illes; Francesco Di Virgilio; Henning Ulrich; Alexey Semyanov; Alexei Verkhratsky; Beata Sperlagh; Shu-Guang Yu; Canhua Huang; Yong Tang
Journal:  Signal Transduct Target Ther       Date:  2021-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.